APIs and intermediates — large — Business MegaBrands 2026–27

Active pharmaceutical ingredients (APIs) are the chemical substances that give a medicine its therapeutic effect, and intermediates are the compounds from which they are synthesised. Large Indian API makers supply these to formulation companies at home and abroad. Their output reduces Indian drug manufacturers' reliance on imported inputs and supports the country's position as a supplier of generic medicines.

Slot BMB-171 · APIs · 7 brands in contention · Business MegaBrand: to be announced in 2027

Brands in contention

Listed alphabetically. The order does not reflect evaluation.

How this category is evaluated

Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology

Frequently asked

Which are the leading API manufacturers in India?

In the Business MegaBrands 2026–27 cohort, the brands in contention for large APIs and intermediates manufacturing are Aarti Drugs, Divi's Laboratories, Granules India, Hikal, Laurus Labs, Neuland Labs and Solara Active Pharma Sciences. This is a list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation.

Other categories in APIs

• Specialty and fermentation APIs
• Generic APIs — mid-size

All of Pharma, Life Sciences & Medtech · The 2026–27 cohort

Cite this page: WCRC, Business MegaBrands 2026–27, APIs and intermediates — large (Slot BMB-171), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/apis-and-intermediates-large/, accessed [date].

WCRC network: WCRC International · WCRC Leaders